HOOKIPA Pharma (HOOK) Competitors $0.95 +0.01 (+1.23%) As of 03:49 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HOOK vs. LTRN, TPST, ATHE, XFOR, TELO, KLTO, IPSC, ACRV, GRCE, and PLURShould you be buying HOOKIPA Pharma stock or one of its competitors? The main competitors of HOOKIPA Pharma include Lantern Pharma (LTRN), Tempest Therapeutics (TPST), Alterity Therapeutics (ATHE), X4 Pharmaceuticals (XFOR), Telomir Pharmaceuticals (TELO), Klotho Neurosciences (KLTO), Century Therapeutics (IPSC), Acrivon Therapeutics (ACRV), Grace Therapeutics (GRCE), and Pluri (PLUR). These companies are all part of the "pharmaceutical products" industry. HOOKIPA Pharma vs. Its Competitors Lantern Pharma Tempest Therapeutics Alterity Therapeutics X4 Pharmaceuticals Telomir Pharmaceuticals Klotho Neurosciences Century Therapeutics Acrivon Therapeutics Grace Therapeutics Pluri HOOKIPA Pharma (NASDAQ:HOOK) and Lantern Pharma (NASDAQ:LTRN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Is HOOK or LTRN more profitable? Lantern Pharma has a net margin of 0.00% compared to HOOKIPA Pharma's net margin of -785.66%. Lantern Pharma's return on equity of -99.89% beat HOOKIPA Pharma's return on equity.Company Net Margins Return on Equity Return on Assets HOOKIPA Pharma-785.66% -120.09% -77.14% Lantern Pharma N/A -99.89%-81.58% Which has better earnings & valuation, HOOK or LTRN? Lantern Pharma has lower revenue, but higher earnings than HOOKIPA Pharma. Lantern Pharma is trading at a lower price-to-earnings ratio than HOOKIPA Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHOOKIPA Pharma$9.35M1.24-$43.50M-$5.85-0.16Lantern PharmaN/AN/A-$20.78M-$1.78-2.42 Does the media favor HOOK or LTRN? In the previous week, Lantern Pharma had 1 more articles in the media than HOOKIPA Pharma. MarketBeat recorded 2 mentions for Lantern Pharma and 1 mentions for HOOKIPA Pharma. Lantern Pharma's average media sentiment score of 0.00 beat HOOKIPA Pharma's score of -0.13 indicating that Lantern Pharma is being referred to more favorably in the news media. Company Overall Sentiment HOOKIPA Pharma Neutral Lantern Pharma Neutral Which has more risk and volatility, HOOK or LTRN? HOOKIPA Pharma has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Lantern Pharma has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Do institutionals & insiders believe in HOOK or LTRN? 63.9% of HOOKIPA Pharma shares are held by institutional investors. Comparatively, 28.6% of Lantern Pharma shares are held by institutional investors. 3.3% of HOOKIPA Pharma shares are held by insiders. Comparatively, 8.5% of Lantern Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts prefer HOOK or LTRN? HOOKIPA Pharma presently has a consensus target price of $4.50, indicating a potential upside of 373.93%. Lantern Pharma has a consensus target price of $25.00, indicating a potential upside of 480.05%. Given Lantern Pharma's stronger consensus rating and higher possible upside, analysts clearly believe Lantern Pharma is more favorable than HOOKIPA Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HOOKIPA Pharma 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Lantern Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryLantern Pharma beats HOOKIPA Pharma on 10 of the 14 factors compared between the two stocks. Get HOOKIPA Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HOOK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HOOK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOOK vs. The Competition Export to ExcelMetricHOOKIPA PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.57M$3.12B$5.77B$9.91BDividend YieldN/A2.29%6.71%4.52%P/E Ratio-0.1620.9775.5426.08Price / Sales1.24290.04480.4288.52Price / CashN/A44.9736.9659.01Price / Book0.229.8611.446.09Net Income-$43.50M-$53.47M$3.28B$266.14M7 Day Performance4.34%2.89%0.84%0.28%1 Month Performance3.22%8.62%7.15%4.14%1 Year Performance-81.42%13.69%59.66%23.93% HOOKIPA Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOOKHOOKIPA Pharma2.3448 of 5 stars$0.95+1.2%$4.50+373.9%-81.6%$11.57M$9.35M-0.16160Short Interest ↑Gap DownLTRNLantern Pharma1.7994 of 5 stars$4.08+0.5%$25.00+512.7%+16.3%$44.06MN/A-2.2920Positive NewsTPSTTempest Therapeutics2.4725 of 5 stars$9.92+0.7%$30.00+202.4%-35.2%$44.05MN/A-0.6820ATHEAlterity Therapeutics2.3692 of 5 stars$4.94-1.6%$12.00+142.9%+240.6%$43.80MN/A0.0010Short Interest ↓Gap UpXFORX4 Pharmaceuticals4.2144 of 5 stars$3.76-8.7%$34.17+808.7%-82.3%$42.84M$2.56M-0.2580Short Interest ↑Gap DownTELOTelomir Pharmaceuticals3.0152 of 5 stars$1.32-10.8%$15.00+1,036.4%-73.9%$42.61MN/A-2.441Short Interest ↓Gap DownKLTOKlotho NeurosciencesN/A$0.69-4.3%N/AN/A$42.58MN/A-1.54N/AGap UpIPSCCentury Therapeutics1.8941 of 5 stars$0.49-2.0%$3.75+665.3%-69.9%$42.48M$6.59M-1.69170Gap UpACRVAcrivon Therapeutics2.5484 of 5 stars$1.34+0.8%$17.57+1,211.3%-84.1%$42.15MN/A-0.6058GRCEGrace Therapeutics2.0393 of 5 stars$3.03+1.3%$12.00+296.0%N/A$41.90MN/A-3.52N/APLURPluri1.938 of 5 stars$5.27+1.9%$12.00+127.7%-8.5%$41.48M$330K-0.95150Gap Up Related Companies and Tools Related Companies Lantern Pharma Competitors Tempest Therapeutics Competitors Alterity Therapeutics Competitors X4 Pharmaceuticals Competitors Telomir Pharmaceuticals Competitors Klotho Neurosciences Competitors Century Therapeutics Competitors Acrivon Therapeutics Competitors Grace Therapeutics Competitors Pluri Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOOK) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HOOKIPA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HOOKIPA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HOOK Stock Alerts